Middle East Healthcare Expansion Business Club Meetings

Fleming Gulf's Middle East Healthcare Expansion Business Club Meetings (12th and 13h of May 2008, Dubai) will gather the upper-level decision makers within the healthcare industry to discuss the hottest issues of the day and obtain solutions for the latest development & expansion programs. The event will provide an exclusive, business-driven environment using prescheduled one-to-one business meetings and educational sessions that are strictly limited to Medial directors and Healthcare specialists.

The program for Middle East HEALTHCARE Expansion 2008 is now updated with new sponsors and international media partners.

Cerner, the leading supplier of healthcare information technology (HIT) solutions has been recently announced as the platinum sponsor for the event. With the growing prominence of e-health in the region, Cerner will be having a dedicated 2 hour workshop on e-health which will be open to all the registered delegates to attend. The latest addition to our sponsoring partners list is that of E3 and Lawson are silver sponsors. E3 has partnered with Lawson's (NASDAQ: LWSN) in the Middle East. By combining Lawson's world class technology products with E3's deep expertise in healthcare and regional practices, they are set to can radically improve your healthcare operations.

Hitachi Data systems, gold sponsor for the event has confirmed their presentation on the topic "Information at the point of care" which will be presented by Mark Clark, Director Healthcare EMEA and Raj Singh, Healthcare Solution Consultant - EMEA.

Philips (silver sponsor) has confirmed their topic for the event as well. Dr. Claus W. Biermann, Vice President Business Development healthcare, Philips International B.V will be presenting on "Total Care Cycle".

Orion Health and RMS India are the key solution providers for this event. Orion is known for the Health's easy-to-use solutions and applications improve patient care and clinical decision making by providing integrated health data in a single, unified view. Where as RMS is the leading manufacturer of medical equipments in the Indian Subcontinent.

In all, the event has 6 major international Healthcare service/solution providers partnered with Fleming Gulf to ensure the success of the event.

The event is hosted in media partnership with BBC World, International Society for Telemidicine and eHealth, Healthcare IT News.eu, Hospital Post, Arab Health World, Arab Medical Tourist.com, Business Intelligence Middle East, Arab Medicare.com and Dubai Health News.com.

Dhanushka Arjuna, Head of BCM (Business Club Meeting) at Fleming Gulf, quotes: "Middle East Healthcare Expansion" congress allows only a limited number of solution providers from each country and category to attend. We work proactively with solution providers before, during and after the event and that builds a true business-driven environment. Our speakers are recruited from top companies and relevant government departments, and represent the best in the industry. Their contributions and shared experiences bring our clients fresh perspectives and viewpoints on their industry, promoting growth and business development. This event would definitely be one amongst those which cannot be missed."

For more information please visit event website www.healthcarebcm.com

About Fleming Gulf
Fleming Gulf is part of the Jacob Fleming Group, one of the world's leading business intelligence companies that provide business-to-business conferences, consultancy services and market research. Jacob Fleming Group offices in Bratislava (Slovakia), Prague (Czech Republic), Budapest (Hungary), Barcelona (Spain), Dubai (UAE) and Cleveland (USA), specialize in organizing prestigious international conferences for Europe and GCC region that provide groundbreaking strategies and proven technical expertise in business functional areas and vertical markets, which include the real estate, energy, finance, media, pharmaceutical and telecom sectors.

Most Popular Now

Pfizer and BioNTech complete submission to Europea…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the European Medicines Agency (EMA) for an Omicron-adapted biva...

AstraZeneca to acquire TeneoTwo and its clinical-s…

AstraZeneca announced an agreement to acquire TeneoTwo, Inc. (TeneoTwo)i, including its Phase I clinical-stage CD19/CD3 T-cell engager, TNB-486, currently under evaluatio...

Bayer to sell men's health product Nebido™ to Grün…

Bayer and Grünenthal have entered into a definitive agreement regarding the sale of Bayer's men's health product Nebido™ (testosterone undecanoate), for a purchase price ...

Pfizer and BioNTech advance COVID-19 vaccine strat…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, active-controlled, observer-blind, Phase 2 study to...

New needle-free nasal vaccine shows promise for CO…

New research shows that a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection. The findings were published in mB...

Demonstration of a potent, universal coronavirus m…

The SARS-CoV-2 that causes COVID-19 has killed 6.3 million people worldwide since 2019, painfully highlighting the vulnerability of humanity to novel coronaviruses. Re...

Disparities in United States COVID-19 vaccine dist…

When reports showed COVID-19 vaccination rates were lower among racial/ethnic minority groups, most discussions focused on mistrust and misinformation among these populat...

SARS-CoV-2 hijacks nanotubes between neurons to in…

COVID-19 often leads to neurological symptoms, such as a loss of taste or smell, or cognitive impairments (including memory loss and concentration difficulties), both dur...

Anti-inflammatory compound shows potential in trea…

An anti-inflammatory compound may have the potential to treat systemic inflammation and brain injury in patients with severe COVID-19 and significantly reduce their chanc...

GSK signs agreement to support pandemic preparedne…

GSK plc (LSE/NYSE: GSK) announced it had signed a framework contract with the European Commission's (EC) Health Emergency Preparedness and Response Authority (HERA) for t...

Vaccine-induced immune response to omicron wanes s…

Although COVID-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substan...

Scientists develop new biomimetic formulation for …

Glioblastoma multiforme (GBM) is an aggressive brain cancer with a poor prognosis and few treatment options. New and effective approaches for GBM treatment are therefore ...